Compare SO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SO | BSX |
|---|---|---|
| Founded | 1945 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.3B | 103.6B |
| IPO Year | N/A | 2010 |
| Metric | SO | BSX |
|---|---|---|
| Price | $93.73 | $69.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 20 |
| Target Price | $98.78 | ★ $107.85 |
| AVG Volume (30 Days) | 5.3M | ★ 10.7M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $8.18 | $12.02 |
| Revenue Next Year | $5.61 | $10.41 |
| P/E Ratio | ★ $22.63 | $36.28 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $83.80 | $67.56 |
| 52 Week High | $100.84 | $109.50 |
| Indicator | SO | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 35.18 |
| Support Level | $92.84 | $67.56 |
| Resistance Level | $96.17 | $76.77 |
| Average True Range (ATR) | 1.65 | 1.89 |
| MACD | -0.56 | 0.43 |
| Stochastic Oscillator | 7.08 | 24.86 |
Southern is one of the largest utilities in the US. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 44 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the US and sells the electricity primarily under long-term contracts.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.